scispace - formally typeset
P

Praveen Surendran

Researcher at University of Cambridge

Publications -  80
Citations -  10539

Praveen Surendran is an academic researcher from University of Cambridge. The author has contributed to research in topics: Genome-wide association study & Population. The author has an hindex of 33, co-authored 71 publications receiving 6651 citations. Previous affiliations of Praveen Surendran include British Heart Foundation & Royal College of Surgeons in Ireland.

Papers
More filters
Journal ArticleDOI

PhenoScanner: a database of human genotype-phenotype associations.

TL;DR: PhenoScanner is a curated database of publicly available results from large-scale genetic association studies that aims to facilitate ‘phenome scans’, the cross-referencing of genetic variants with many phenotypes, to help aid understanding of disease pathways and biology.
Journal ArticleDOI

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.

Evangelos Evangelou, +341 more
- 17 Sep 2018 - 
TL;DR: In this article, the largest genetic association study of blood pressure traits (systolic, diastolic and pulse pressure) to date in over 1 million people of European ancestry was conducted.
Journal ArticleDOI

PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations

TL;DR: A major update of PhenoScanner is presented, including over 150 million genetic variants and more than 65 billion associations with diseases and traits, gene expression, metabolite and protein levels, and epigenetic markers.
Journal ArticleDOI

Exome-wide association study of plasma lipids in > 300,000 individuals

Dajiang J. Liu, +288 more
- 30 Oct 2017 - 
TL;DR: It is found that beta-thalassemia trait carriers displayed lower TC and were protected from coronary artery disease (CAD), and only some mechanisms of lowering LDL-C appeared to increase risk for type 2 diabetes (T2D); and TG-lowering alleles involved in hepatic production of TG-rich lipoproteins tracked with higher liver fat, higher risk for T2D, and lower risk for CAD.